Atlas Trials

Relapsed Small Cell Lung Cancer

9 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch Relapsed Small Cell Lung Cancer

RecordFirmDate
Clinical Trial of Lurbinectedin as Single-agent or in Combination With Irinotecan Versus Topotecan or Irinotecan in Patients With Relapsed Small-cell Lung Cancer (LAGOON) (NCT05153239)PharmaMar2022-07-22
Venetoclax and Irinotecan in Relapsed/Refractory SCLC (NCT04543916)Virginia Commonwealth University2021-06-30
Safety and Tolerability Evaluation of Low-dose Radiation in Combination With CS1001 in Relapsed SCLC Patients (NCT04421352)CStone Pharmaceuticals2021-01-12
Immune Checkpoint Inhibition With Lurbinectedin Relapsed/Recurrent SCLC (NCT04610658)H. Lee Moffitt Cancer Center and Research Institute2020-11-23
A Single-arm, Phase Ⅱ Clinical Trial of Anlotinib Hydrochloride Combined With Irinotecan or Docetaxel for Second Line Treatment of Nonsensitive Relapsed Small-cell Lung Cancer (NCT04757779)First People's Hospital of Hangzhou2019-12-30
Combination Immunotherapy-Ipilimumab-Nivolumab-Dendritic Cell p53 Vac - Patients With Small Cell Lung Cancer (SCLC) (NCT03406715)H. Lee Moffitt Cancer Center and Research Institute2018-03-15

Track Relapsed Small Cell Lung Cancer automatically

Every clearance here is in the API, with alerts when new ones post.